Cempra Pharmaceuticals, Inc. of New York to Ring The NASDAQ Stock Market Closing Bell in Celebration of Initial Public Offering (IPO)

ADVISORY, Feb. 15, 2012 (GLOBE NEWSWIRE) -- What: Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, will visit the NASDAQ MarketSite in Times Square. Cempra visits in celebration of its initial public offering, which took place on January 3, 2012 on The NASDAQ Global Market under the ticker symbol, "CEMP."